NCT01988584View on ClinicalTrials.gov

Safety and Effectiveness of Banked Cord Blood or Bone Marrow Stem Cells in Children With Cerebral Palsy (CP).

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

February 21, 2018

Study Completion Date

February 21, 2018

Conditions
Cerebral Palsy
Interventions
BIOLOGICAL

umbilical cord blood (hUCB) cells

Autologous umbilical cord blood banked with the Cord Blood Registry.

DRUG

Saline Infusion (Placebo)

A total of 10 children (5 from each cohort) will be randomized to a placebo infusion at the baseline visit and then have the opportunity to cross-over to stem cell treatment at the 1yr. visit.

BIOLOGICAL

bone marrow derived mononuclear cells (BMMNCs)

Autologous stem cells from bone marrow harvest.

Trial Locations (1)

77030

UTHealth, Medical School, Dept. of Pediatric Surgery, Houston

All Listed Sponsors
collaborator

Cord Blood Registry, Inc.

INDUSTRY

collaborator

Let's Cure CP Foundation

OTHER

collaborator

Mission Connect, a program of TIRR Foundation

UNKNOWN

lead

The University of Texas Health Science Center, Houston

OTHER

NCT01988584 - Safety and Effectiveness of Banked Cord Blood or Bone Marrow Stem Cells in Children With Cerebral Palsy (CP). | Biotech Hunter | Biotech Hunter